Kenneth Ogan, MD
Urology · Atlanta, GANPI 1477584423
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Verathon Inc. at 27.8% of the total. That places this record below the midpoint for urology clinicians in GA, where the typical reported total is $4,062.
Across 17 payments — averaging $79.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Verathon Inc.$375
- Cook Incorporated$250
- Cook Medical LLC$236
- Novo Nordisk$163
- Baxter Healthcare$111
- KARL Storz Endoscopy-america$100
- plus $112 from 2 others
Across 155 payments — averaging $2731.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$423K
What the payments were for
- Consulting fees$37528%
- Speaking & faculty fees$25019%
- Food & beverage$70853%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Verathon Inc. | 1 | $375 |
| Cook Incorporated | 1 | $250 |
| Cook Medical LLC | 3 | $236 |
| Novo Nordisk | 3 | $163 |
| Baxter Healthcare | 1 | $111 |
| KARL Storz Endoscopy-america | 1 | $100 |
| Photocure Inc | 1 | $98 |
| Travere Therapeutics, Inc. | 6 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,348 in reported general payments places this provider in the 30th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 172 | $1,576 |
| Potassium Citrate ErPotassium Citrate | 18 | $1,348 |
| Oxybutynin Chloride ErOxybutynin Chloride | 31 | $569 |
| Finasteride | 34 | $335 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 50 | $161 |
| Methocarbamol | 18 | $136 |
| Gabapentin | 19 | $116 |
| Tramadol Hcl | 18 | $30 |
| Sildenafil Citrate | 13 | $25 |
Paid to pharmacies, not to this prescriber.
Other urology in Atlanta
- Tariq HakkyAtlanta$140K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
- Matthew SandAtlanta$77K
- Brendan BrowneAtlanta$53K
- Rajesh LaunganiAtlanta$33K
- Vikram NarayanAtlanta$29K
- Gregory MitchellAtlanta$15K
- Charles LorentzAtlanta$14K
- Vahan KassabianRoswell$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.